Myalepta (metreleptin) 5.8 mg vial: shortage and mitigation plan
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Myalepta
|
Active substance |
Metreleptin
|
Therapeutic area (MeSH) |
Lipodystrophy, Familial Partial
|
Procedure number |
EMEA/H/C/004218
|
DHPC type |
Medicine shortage
|
Human ATC code |
A16AA
|
Dissemination date |
03/03/2023
|